Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

Conditions

• Generalized Myasthenia Gravis

Interventions

• OTHER: Placebo
• DRUG: Cladribine Low Dose
• DRUG: Cladribine High Dose

Sponsor

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Collaborators

• [object Object]